$8.20
8.18% yesterday
Nasdaq, Nov 26, 10:00 pm CET
ISIN
KYG596651029
Symbol
MGTX

MeiraGTx Holdings plc Stock price

$8.20
-0.67 7.55% 1M
+3.10 60.78% 6M
+2.11 34.65% YTD
+1.81 28.33% 1Y
+1.86 29.34% 3Y
-5.53 40.28% 5Y
-6.80 45.33% 10Y
-6.80 45.33% 20Y
Nasdaq, Closing price Wed, Nov 26 2025
+0.62 8.18%
ISIN
KYG596651029
Symbol
MGTX
Industry

Key metrics

Basic
Market capitalization
$660.0m
Enterprise Value
$701.6m
Net debt
$41.6m
Cash
$32.2m
Shares outstanding
80.5m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
17.4 | 9.4
EV/Sales
18.5 | 10.0
EV/FCF
negative
P/B
223.0
Financial Health
Equity Ratio
25.1%
Return on Equity
-217.9%
ROCE
-108.7%
ROIC
-
Debt/Equity
24.9
Financials (TTM | estimate)
Revenue
$37.9m | $70.1m
EBITDA
$-145.3m | $79.9m
EBIT
$-157.9m | $-114.5m
Net Income
$-157.5m | $-148.3m
Free Cash Flow
$-134.0m
Growth (TTM | estimate)
Revenue
367.0% | 110.6%
EBITDA
6.4% | 148.7%
EBIT
6.7% | 30.3%
Net Income
-69.1% | -0.4%
Free Cash Flow
-27.9%
Margin (TTM | estimate)
Gross
26.6%
EBITDA
-383.3% | 114.0%
EBIT
-416.5%
Net
-415.4% | -211.6%
Free Cash Flow
-353.3%
More
EPS
$-2.0
FCF per Share
$-1.7
Short interest
7.3%
Employees
378
Rev per Employee
$90.0k
Show more

Is MeiraGTx Holdings plc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,049 stocks worldwide.

MeiraGTx Holdings plc Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a MeiraGTx Holdings plc forecast:

12x Buy
92%
1x Hold
8%

Analyst Opinions

13 Analysts have issued a MeiraGTx Holdings plc forecast:

Buy
92%
Hold
8%

Financial data from MeiraGTx Holdings plc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
38 38
367% 367%
100%
- Direct Costs 28 28
-
73%
10 10
-
27%
- Selling and Administrative Expenses 51 51
11% 11%
136%
- Research and Development Expense 117 117
11% 11%
307%
-145 -145
6% 6%
-383%
- Depreciation and Amortization 13 13
9% 9%
33%
EBIT (Operating Income) EBIT -158 -158
7% 7%
-416%
Net Profit -158 -158
69% 69%
-415%

In millions USD.

Don't miss a Thing! We will send you all news about MeiraGTx Holdings plc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

MeiraGTx Holdings plc Stock News

Neutral
PRNewsWire
7 days ago
NEW YORK , Nov. 20, 2025 /PRNewswire/ -- Graviton Bioscience Corporation, a clinical-stage biotechnology company developing selective ROCK2 inhibitors for metabolic, inflammatory, fibrotic, and central nervous system disorders, among other therapeutic indications, today announced that Samuel Waksal, Ph.D., Chief Executive Officer, will participate in a fireside chat at the 8th Annual Evercore H...
Neutral
GlobeNewsWire
14 days ago
LONDON and NEW YORK, Nov. 13, 2025 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical-stage genetic medicines company, today announced financial and operational results for the third quarter ended September 30, 2025, and provided a corporate update.
Positive
Seeking Alpha
15 days ago
MeiraGTx Holdings plc secures a transformative partnership with Eli Lilly, granting worldwide rights to its AAV-AIPL1 gene therapy for LCA4. MGTX receives $75 million upfront, up to $400 million in milestones, and tiered royalties, strengthening its financial position and reducing near-term dilution risk. The company's riboswitch technology and multiple collaborations, including with Johnson & ...
More MeiraGTx Holdings plc News

Company Profile

MeiraGTx Holdings Plc is a clinical-stage biotech company, which engages in the development of novel gene therapy treatments. It operates through the United States and United Kingdom geographical segments. Its pipeline includes AAV-CNGB3, AAV-CNGA3, AAV-RPE65, AAV-RPGR, AAV-AQP1 and AAV-UPF1. The company was founded on March 20, 2015 and is headquartered in New York, NY.

Head office Cayman Islands
CEO Alexandria Forbes
Employees 378
Founded 2015
Website meiragtx.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today